1-3 of 3
Akihiro Ihara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells

Keichiro Mihara, MD, PhD, Joyeeta Bhattacharyya, MD, PhD, Akira Kitanaka, MD, PhD, Akihiro Ihara, MD, PhD, Akira Sakai, MD, PhD, Yoshiaki Kuroda, MD, PhD, Hideki Asaoku, MD, Yoshihiro Takihara, MD, PhD, Akiro Kimura, MD
Journal: Blood
Blood (2011) 118 (21): 885.
https://doi.org/10.1182/blood.V118.21.885.885
Published: 2011
Journal Articles

Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis

Clinical Trials & Observations Brief Report
Keichiro Mihara, Moniruddin Chowdhury, Nanae Nakaju, Sachiko Hidani, Akihiro Ihara, Hideo Hyodo, Shin'ichiro Yasunaga, Yoshihiro Takihara, Akiro Kimura
Journal: Blood
Blood (2006) 107 (1): 305–308.
https://doi.org/10.1182/blood-2005-06-2393
Published: 2006
Journal Articles

Bmi-1 Expression Predicts the Progression of Malignant Hematopoietic Stem Cells in Myelodysplastic Syndrome.

Keichiro Mihara, Nanae Nakaju, Sachiko Hidani, Moniruddin Chowdhury, Akihiro Ihara, Akiro Kimura
Journal: Blood
Blood (2004) 104 (11): 3425.
https://doi.org/10.1182/blood.V104.11.3425.3425
Published: 2004